DE68928644T2 - Heterocyclische Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen - Google Patents

Heterocyclische Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen

Info

Publication number
DE68928644T2
DE68928644T2 DE68928644T DE68928644T DE68928644T2 DE 68928644 T2 DE68928644 T2 DE 68928644T2 DE 68928644 T DE68928644 T DE 68928644T DE 68928644 T DE68928644 T DE 68928644T DE 68928644 T2 DE68928644 T2 DE 68928644T2
Authority
DE
Germany
Prior art keywords
sulphur
nitrogen
chem
oxygen
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE68928644T
Other languages
English (en)
Other versions
DE68928644D1 (de
Inventor
Barry Sidney Beecham Pha Orlek
Richard Eric Beecham Faulkner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888824071A external-priority patent/GB8824071D0/en
Priority claimed from GB888830223A external-priority patent/GB8830223D0/en
Priority claimed from GB898920660A external-priority patent/GB8920660D0/en
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Publication of DE68928644D1 publication Critical patent/DE68928644D1/de
Application granted granted Critical
Publication of DE68928644T2 publication Critical patent/DE68928644T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Furan Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE68928644T 1988-10-13 1989-10-11 Heterocyclische Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen Expired - Fee Related DE68928644T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB888824071A GB8824071D0 (en) 1988-10-13 1988-10-13 Novel compounds
GB888830223A GB8830223D0 (en) 1988-12-23 1988-12-23 Novel compounds
GB898920660A GB8920660D0 (en) 1989-09-18 1989-09-18 Novel compounds

Publications (2)

Publication Number Publication Date
DE68928644D1 DE68928644D1 (de) 1998-05-20
DE68928644T2 true DE68928644T2 (de) 1998-08-27

Family

ID=27264121

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68928644T Expired - Fee Related DE68928644T2 (de) 1988-10-13 1989-10-11 Heterocyclische Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen

Country Status (9)

Country Link
US (1) US5166357A (de)
EP (1) EP0366304B1 (de)
JP (1) JP2934743B2 (de)
AT (1) ATE165095T1 (de)
AU (1) AU4278289A (de)
CA (1) CA2000041A1 (de)
DE (1) DE68928644T2 (de)
DK (1) DK504889A (de)
PT (1) PT91956B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ227684A (en) * 1988-01-30 1991-07-26 Merck Sharp & Dohme Pyrazine, pyridazine, and pyrimidine derivatives and pharmaceutical compositions
EP0402056A3 (de) * 1989-06-06 1991-09-04 Beecham Group p.l.c. Azabicyclische Verbindungen, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
EP0413545B1 (de) * 1989-08-16 1997-05-14 Beecham Group Plc Azabicyclische Verbindungen
ATE136031T1 (de) * 1989-10-07 1996-04-15 Beecham Group Plc Azabizyklische verbindungen, verfahren und zwischenprodukte zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
EP0563036A1 (de) * 1990-12-21 1993-10-06 Merck Sharp & Dohme Ltd. 4-azatricyclo[2.2.1.0 2,6]heptanderivate und arzneimittel
AU7125096A (en) * 1995-09-22 1997-04-09 Novo Nordisk A/S Novel substituted azacyclic or azabicyclic compounds
US5733912A (en) * 1997-02-19 1998-03-31 Abbott Laboratories 7A-heterocycle substituted hexahydro-1H-pyrrolizine compounds useful in controlling chemical synaptic transmission
CN1204131C (zh) 1999-03-30 2005-06-01 纳幕尔杜邦公司 制备α－亚甲基内酯的方法
WO2000058298A2 (en) * 1999-03-30 2000-10-05 E.I. Du Pont De Nemours And Company PROCESS FOR THE PREPARATION OF α-METHYLENELACTONES AND α-SUBSTITUTED HYDROCARBYLIDENE LACTONES
US6362346B1 (en) 1999-11-12 2002-03-26 E. I. Du Pont De Nemours And Company Process for the preparation of α-methylene-γ-butyrolactone and α-acetoxymethyl-γ-butyrolactone
US6642346B2 (en) 2000-02-28 2003-11-04 E. I. Du Pont De Nemours And Company Coating compositions containing substituted and unsubstituted exomethylene lactone or lactam monomers
US6531616B2 (en) 2000-12-22 2003-03-11 E. I. Du Pont De Nemours And Company Process for the preparation of a-methylenelactones and a-substituted hydrocarbylidene lactones
KR100428408B1 (ko) * 2001-12-14 2004-04-28 학교법인 성균관대학 α-메틸렌-γ-부티로락톤의 제조방법
DE60301127T2 (de) 2002-01-07 2006-04-20 E.I. Du Pont De Nemours And Co., Wilmington Methylenlacton synthese in superkritischen flüssigkeiten
WO2003057686A1 (en) 2002-01-07 2003-07-17 E.I. Du Pont De Nemours And Company Alpha-methylenelactone synthesis in supercritical fluids
CA2620333A1 (en) * 2005-08-26 2007-03-01 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
EP2258358A3 (de) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenese mit Acetylcholinesterasehemmer
MX2009002496A (es) * 2006-09-08 2009-07-10 Braincells Inc Combinaciones que contienen un derivado de 4-acilaminopiridina.
CN102276559B (zh) * 2011-08-12 2014-05-28 河北威远生化农药有限公司 3-羟甲基四氢呋喃的合成方法
WO2023151894A1 (en) 2022-02-11 2023-08-17 Henkel Ag & Co. Kgaa Process for the synthesis of alpha-methylene-gamma-butyrolactone

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ219646A (en) * 1986-03-27 1990-10-26 Merck Sharp & Dohme Oxadiazole derivatives of azacyclics for treating cns disorders
GB8615785D0 (en) * 1986-06-27 1986-08-06 Beecham Group Plc Compounds
EP0261763B1 (de) * 1986-06-27 1994-02-09 Beecham Group Plc Verbrückte bicyclische N-heterocyclische Verbindungen
ATE133415T1 (de) * 1987-04-15 1996-02-15 Beecham Group Plc Am brückenkopf substituierte azabicyclenderivate
NZ225999A (en) * 1987-09-10 1992-04-28 Merck Sharp & Dohme Azacyclic- or azabicyclic-substituted thiadiazole derivatives and pharmaceutical compositions
DE3877470T2 (de) * 1987-09-10 1993-06-24 Merck Sharp & Dohme Oxazole und thiazole zur behandlung seniler demenz.
IL88156A (en) * 1987-11-13 1997-02-18 Novo Nordisk As Azacyclic compounds their preparation and pharmaceutical compositions containing them
EP0322182A3 (de) * 1987-12-22 1992-01-02 Beecham Group Plc Azabicyclische-Verbindungen, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen

Also Published As

Publication number Publication date
DK504889A (da) 1990-04-14
US5166357A (en) 1992-11-24
JP2934743B2 (ja) 1999-08-16
EP0366304A2 (de) 1990-05-02
PT91956B (pt) 1995-05-31
AU4278289A (en) 1990-04-26
EP0366304A3 (de) 1991-09-11
PT91956A (pt) 1990-04-30
ATE165095T1 (de) 1998-05-15
DE68928644D1 (de) 1998-05-20
EP0366304B1 (de) 1998-04-15
CA2000041A1 (en) 1990-04-13
JPH02134380A (ja) 1990-05-23
DK504889D0 (da) 1989-10-11

Similar Documents

Publication Publication Date Title
DE68928644T2 (de) Heterocyclische Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
DE3854932T2 (de) Am Brückenkopf substituierte Azabicyclenderivate
DE69107250T2 (de) Neue 4-Aminobuttersäurederivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneizubereitungen.
ZA911402B (en) Aminomethylpiperidine derivatives,process for preparing these and pharmaceutical compositions containing them
ATE63125T1 (de) Peptidderivate mit polyzyklischer stickstoffstruktur, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen.
ES2043834T3 (es) Un procedimiento para preparar nuevos derivados de androsta-1,4-dien-3-ona sustituida en la posicion 17.
DE69026197D1 (de) Azabizyklische Verbindungen, Verfahren und Zwischenprodukte zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
AU629668B2 (en) Heterocyclic substituted azabicyclic compounds for pharmaceutical use
DK330588A (da) Tripeptidderivater med en polycyklisk nitrogenholdig struktur, fremgangsmaade til deres fremstilling og farmaceutiske midler indeholdende dem
ATE169015T1 (de) Aminobenzoesäure derivate
SE8001425L (sv) Cytostatiskt verkande lekemedel resp farmaceutiska beredningar
DE69030695D1 (de) Azabicyclische Verbindungen
DE69409774D1 (de) Neue kardioaktive 17-Iminomethylalkenyl-5-beta-14-beta-androstan und 17-Iminoalkyl-5-beta, 14-beta-androstan Derivate, ein Verfahren zu ihrer Herstellung und pharmazeutische Präparate davon

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee